US Patent 7718678 Di-substituted oxadiazoles as CXC-chemokine receptor ligands
Patent 7718678 was granted and assigned to Schering on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+53 characters)
Article
Patent abstract
Disclosed are compounds of the formula
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718678 Di-substituted oxadiazoles as CXC-chemokine receptor ligands US Patent 7718678 Di-substituted oxadiazoles as CXC-chemokine receptor ligands
Infobox
Patent Number
0771867800
Patent Number
771867800
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077186780
Date of Patent
May 18, 2010
0Patent Application Number
114758110
Date Filed
June 27, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077186780
Date of Patent
May 18, 2010
0Patent Application Number
114758110
Date Filed
June 27, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718678 Di-substituted oxadiazoles as CXC-chemokine receptor ligands
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718678
Date of patent
May 18, 2010
Patent application number
11475811
Date Filed
June 27, 2006
Patent primary examiner
Find more entities like US Patent 7718678 Di-substituted oxadiazoles as CXC-chemokine receptor ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
